World Aquaculture Singapore 2026

June 2-5, 2026

Singapore

IN VITRO, EX VIVO AND IN VIVO ASSESSMENT OF THE CHINESE HERBAL MIXTURE IN NILE TILAPIA Oreochromis niloticus ON IMMUNE RESPONSE, GUT MICROBIOTA MODULATION, ANTIBACTERIAL ACTIVITY AGAINST Streptococcus agalactiae

Ari Widodo*, Loo Say Chye Joachim a, Fan-Hua Nan b

 

School of Materials Science and Engineering (MSE)
Nanyang Technological University

Singapore

ari.widodo@ntu.edu.sg 



Ban Xia Xie Xin Tang (BXT) is a Chinese herbal mixture made from several herbs with antioxidant, anti-inflammatory, and antibacterial properties. In response to the rising cases of Streptococcus agalactiae infection in tilapia aquaculture, this study examined the in vitro , ex vivo , and in vivo immunostimulatory and antibacterial effects of BXT  following infection with S. agalactiae . The results showed that 250 mg/L of BXT was the best dose for improving tilapia immune responses, including respiratory burst activity, phagocytic activity, and phagocytic index. BXT had a dose-dependent antibacterial effect against S. agalactiae , shown by larger inhibition zones and confirmed by MIC and MBC tests.  In the ex vivo experiment , BXT helped maintain head kidney leukocytes during bacterial challenge and increased the expression of immune-related genes (such as lgb , ontlr5s , tnfα , il1β , sod , gpx , cat , ßdefen1 , hepcidin2 , and tp3) in several organs, including the head kidney, spleen, liver, gill, gut, and muscle, with 250 mg/L as the optimal dose.  In the in vivo challenge, fish were divided into three groups: negative control (NC), positive control (PC), and BXT250 (250 mg/L of BXT supplementation).  Dietary supplementation with BXT250 increased the survival rate of tilapia to 90% following S. agalactiae infection.  This was supported by histological analysis of the liver, spleen, and gills, where the PC group showed severe vacuolation, hemolysis, and lamellar damage, whereas fish treated with BXT250 largely maintained normal tissue architecture with only mild hemolysis and lamellar alterations. The BXT250 group also upregulated igm and igt expression in both systemic and mucosal organs compared with the NC and PC groups. Moreover, predicted functions of the gut microbiota differed among NC, PC, and BXT250 groups, with numerous metabolic and biosynthetic pathways enriched in BXT250 compared with the challenged PC group, suggesting improved functional potential under BXT250 feeding. Collectively, these findings support the potential application of BXT as an immunostimulant and antimicrobial agent in tilapia aquaculture.